A popular breast cancer drug is getting a thumbs down from the FDA and many medical experts. As a cosmetic and reconstructive plastic surgeon Dr. Stuart Kincaid helps many breast cancer patients with the process of breast reconstruction. He is committed to educating all of his breast surgery patients about the importance of good breast health. At the very minimum this includes monthly breast self exam. This includes breast augmentation patients with breast implants, breast reduction, and breast lift patients. Some may also be advised to have an annual mammogram as well. It is the hope of Dr. Stuart Kincaid and his staff that breast cancer will no longer be a concern for women. It is very disappointing that a recent breast cancer drug that once showed promise is no longer considered effective. According to CBS 8 oncologists and even some breast cancer support groups are endorsing a U.S. health advisory panel’s recommendation that the blockbuster cancer drug Avastin be removed for use in metastatic breast cancer.
The reason: There’s still a lack of understanding of how the drug works or who it helps.
Avastin was given fast-track approval by the U.S. Food and Drug Administration in 2008 to be used, in combination with the chemotherapy drug Taxol, by women with metastatic HER2-negative breast cancer.
But a six-member FDA panel of cancer experts said Wednesday that the drug was not effective, caused dangerous side effects and its approval should be revoked.
Schedule your Consultation Today!
More on Dr.Kincaid
Become a Fan on Facebook
Follow us on Twitter